Nutrition Research
Volume 23, Issue 1 , Pages 123-130 , January 2003

The effects of estrogen depletion and isoflavones on bone metabolism in rats

  • Farzad Deyhim

      Affiliations

    • Department of Human Sciences, University of Arkansas, Pine Bluff, AR 71601, USA
    • ,
  • Barbara J. Stoecker

      Affiliations

    • Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA
    • ,
  • Gerald H. Brusewitz

      Affiliations

    • Department of Biosystems & Agricultural Engineering, Oklahoma State University, Stillwater, OK 74078, USA
    • ,
  • Bahram H. Arjmandi

      Affiliations

    • Department of Nutritional Sciences, Oklahoma State University, Stillwater, OK 74078, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-405-744-4437; fax: +1-405-744-7113.

Received 28 February 2002 ,Revised 16 August 2002 ,Accepted 20 August 2002.

References 

  1. Gallagher JC. Role of estrogens in the management of postmenopausal bone loss. Rheum Dis Clin North Am. 2001;27:143–162
  2. Morishige K, Matsumoto K, Ohmichi M, Nishio Y, Adachi K, Hayakawa J, et al. Clinical features affecting the results of estrogen replacement therapy on bone density in Japanese postmenopausal women. Gynecol Obstet Invest. 2001;52:223–226
  3. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol. 1997;146:294–296
  4. Lacey JV, Mink PJ, Lubin JH, Sherman ME, Troisi R, Hartge P, et al. Menopausal hormone replacement therapy and risk of ovarian cancer. JAMA. 2002;288:334–341
  5. Mei J, Yeung SS, Kung AW. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab. 2001;86:5217–5221
  6. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States (the Framingham study (1–4)). J Nutr. 2001;131:1826–1832
  7. Greendale GA, FitzGerald G, Huang MH, Sternfeld B, Gold E, Seeman T, et al. Dietary soy isoflavones and bone mineral density (results from the study of women’s health across the nation). Am J Epidemiol. 2002;155:746–754
  8. Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr. 1996;126:161–167
  9. Arjmandi BH, Birnbaum RS, Juma S, Barengolts E, Kukreja SC. The synthetic phytoestrogen, ipriflavone, and estrogen prevents bone loss by different mechanisms. Calcif Tissue Int. 2000;66:61–65
  10. Ettinger B, Goldith IM, Friedman G. Gynecologic consequences of long-term unopposed estrogen replacement therapy. Maturitas. 1988;10:271–282
  11. Cheng SL, Zhang SF, Nelson TL, Warlow PM, Civitelli R. Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int. 1994;55:356–362
  12. Cecchini MG, Fleisch H, Muhlbauer RC. Ipriflavone inhibits bone resorption in intact and ovariectomized rats. Calcif Tissue Int. 1997;61:S9–S11
  13. Nakamura S, Morimoto S, Takamoto S, Onishi T, Fukuo K, Koh E, et al. Effect of ipriflavone on bone mineral density and calcium related factors in elderly females. Calcif Tissue Int. 1992;51:S30–S34
  14. Civitelli R, Abbasi-Jahromi SH, Halstead LR, Dimarogonas A. Ipriflavone improves bone density and biochemical properties of adult male rat bones. Calcif Tissue Int. 1995;56:215–219
  15. Reeves PG, Nielsen FH, Fahey Jr. GC. AIN-93 purified diets for laboratory rodents (final report of the American Institute of Nutrition Ad Hoc writing committee on the reformulation of the AIN-76A rodent diet). J Nut. 1993;123:1931–1951
  16. Kiebzak GM, Smith R, Gundberg CC, Howe JC, Sacktor B. Bone status of senescent male rats (chemical, morphometric, and mechanical analysis). J Bone Min Res. 1988;3:37–45
  17. Kalu DN, Masoro EJ, Byung PY, Hardin RR, Hollis BW. Modulation of age-related hyperparathyrodism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology. 1988;122:1847–1854
  18. SAS Institute. User’s Guide (statistics). Cary, NC: SAS Institute, Inc; 1999;
  19. Kalu DN, Arjmandi BH, Liu CC, Salih MA, Birnbaum RS. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3. Bone Min. 1994;24:135–148
  20. Thomas DK, Storlien LH, Bellingham WP, Gillette K. Ovarian hormone effects on activity, glucoregulation and thyroid hormones in the rats. Physiol Behav. 1986;36:567–573
  21. Risteli L, Risteli J. Biochemical markers of bone metabolism. Annal Med. 1993;25:385–393
  22. Minkin C. Bone acid phosphatase. Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int. 1982;34:285–290
  23. Gaumet N, Seibel MJ, Coxam V, Davicco MJ, Lebecque P, Barlet JP. Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats. Arch Physiol Biochem. 1997;105:435–444
  24. Toda T, Uesugi T, Hirai K, Nukaya H, Tsuji K, Ishida H. New 6-O-acyl isoflavone glycosides from soybeans fermented with Bacillus subtilis (natto). I. 6-O-succinylated isoflavone glycosides, and their preventive effects on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull. 1999;22:1193–1201
  25. Peng ZQ, Vaananen HK, Zhang HX, Tukkanen J. Long term effects of ovariectomy on the mechanical properties and chemical composition of rat bone. Bone. 1997;20:207–212
  26. Faulkner KG. Bone matters (are density increases necessary to reduce fracture risk). J Bone Min Res. 2000;15:183–187

PII: S0271-5317(02)00477-3

Nutrition Research
Volume 23, Issue 1 , Pages 123-130 , January 2003

Article Tools